– Fapon Biopharma anuncia la aprobación por la FDA del IND para FP008, una inmunoterapia de primera clase para tumores sólidos DONGGUAN, China, 28 de febrero de 2025 /PRNewswire/ — Fapon Biopharma, empresa biotecnológica innovadora en el desarrollo de anticuerpos terapéuticos y proteínas…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.